Social media is healthcare’s new superhero, full of high-flying promise and an armoury of positive patient and HCP ...

If approved, it would be the only FDA-approved, oral, non-hormonal treatment for pattern hair loss in both male and female ...

Only 19% of clinicians trust pharma-branded touchpoints, while 86% trust peer-to-peer content. It’s a new reality for medical ...

The companies that prevail will not be those with the best assets, but those that help build an integrated ecosystem around ...

Plaque psoriasis is an inflammatory condition that causes red, scaly and often itchy or painful patches of skin ...

Novartis has presented positive results from two phase 3 trials measuring its BTK inhibitor, remibrutinib, against ...

Eli Lilly has appointed Ilya Yuffa as executive vice president and president, Lilly Global Markets, effective as of 1 January ...

Spica Therapeutics has appointed Jeff Abbey as Chief Executive Officer (CEO). Abbey joins Spica with more than twenty years ...

The Krascendo 1 study showed improved survival rates of 18 months compared to 12 months with current standard of care ...

Merck & Co/MSD has set another part of its ongoing cost-cutting drive in motion, announcing the closure of a plant in France that will result in 207 job losses across manufacturing and R&D. In the ...

New research by the Medicines and Healthcare products Regulatory Agency (MHRA), in partnership with the GSK Vaccines Institute for Global Health, has moved a vaccine against the highly contagious ...

Eli Lilly is suing ten medical spas, wellness centres and compounding pharmacies to stop the “unlawful marketing” and sales of products fraudulently claiming to be Mounjaro (tirzepatide). Lilly said ...